title: PARP inhibitors: the race is on.
authors.affiliation: Drug Development Unit, Royal Marsden Hospital, London, UK.|Division of Clinical Studies, The Institute of Cancer Research, London, UK.
authors.forename: Jessica S
authors.initials: JS
authors.lastname: Brown
authors.affiliation: Drug Development Unit, Royal Marsden Hospital, London, UK.|Division of Clinical Studies, The Institute of Cancer Research, London, UK.
authors.forename: Stan B
authors.initials: SB
authors.lastname: Kaye
authors.affiliation: Drug Development Unit, Royal Marsden Hospital, London, UK.|Division of Clinical Studies, The Institute of Cancer Research, London, UK.
authors.forename: Timothy A
authors.initials: TA
authors.lastname: Yap
mesh_terms: D019313:BRCA1 Protein / Q000235:genetics*; D024682:BRCA2 Protein / Q000235:genetics*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D018095:Germ-Line Mutation / Q000235:genetics*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D019313:BRCA1 Protein; D024682:BRCA2 Protein; D007211:Indoles